Skip to main content

Peer Review reports

From: Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

Original Submission
25 Dec 2021 Submitted Original manuscript
31 Jan 2022 Reviewed Reviewer Report
1 Feb 2022 Reviewed Reviewer Report
17 Feb 2022 Author responded Author comments - Kadir ESER
Resubmission - Version 2
17 Feb 2022 Submitted Manuscript version 2
23 Mar 2022 Reviewed Reviewer Report
27 Mar 2022 Reviewed Reviewer Report
8 Apr 2022 Author responded Author comments - Kadir ESER
Resubmission - Version 3
8 Apr 2022 Submitted Manuscript version 3
9 Apr 2022 Author responded Author comments - Kadir ESER
Resubmission - Version 4
9 Apr 2022 Submitted Manuscript version 4
15 Apr 2022 Author responded Author comments - Kadir ESER
Resubmission - Version 5
15 Apr 2022 Submitted Manuscript version 5
Publishing
25 Apr 2022 Editorially accepted
7 May 2022 Article published 10.1186/s12885-022-09624-y

You can find further information about peer review here.

Back to article page